SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

15 May 2023 Evaluate
The company witnessed a 19.83% growth in the revenue at Rs. 3209.20 millions for the quarter ended March 2023 as compared to Rs. 2678.20 millions during the year-ago period.Net profit stood at Rs. 591.90  millions  compared to Rs. 511.60 millions in the corresponding previous quarter,high by 15.70%.Operating profit surged to 846.30 millions from the corresponding previous quarter of 711.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202206 202106 % Var
Sales 3209.20 2678.20 19.83 9284.40 8185.20 13.43 11144.10 10087.30 10.48
Other Income 49.70 23.50 111.49 129.30 100.90 28.15 131.90 181.00 -27.13
PBIDT 846.30 711.20 19.00 2937.90 2187.70 34.29 2808.70 2641.20 6.34
Interest 2.10 1.40 50.00 6.00 4.00 50.00 4.20 8.00 -47.50
PBDT 844.20 709.80 18.93 2931.90 2183.70 34.26 2804.50 2633.20 6.51
Depreciation 58.90 61.20 -3.76 231.20 196.10 17.90 270.80 300.40 -9.85
PBT 785.30 648.60 21.08 2700.70 1987.60 35.88 2533.70 2332.80 8.61
TAX 193.40 137.00 41.17 704.20 473.90 48.60 608.50 564.80 7.74
Deferred Tax -33.70 -5.90 471.19 -42.60 -10.90 290.83 0.40 -49.00 -100.82
PAT 591.90 511.60 15.70 1996.50 1513.70 31.90 1925.20 1768.00 8.89
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 26.37 26.56 -0.69 31.64 26.73 18.39 25.20 26.18 -3.74

Procter&Gamble Healt Share Price

5021.30 29.00 (0.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×